IT7921854A0 - Impiego di antiestrogeni e antiandrogeni ad azione antigonadotropa per la profilassi e la terapia della iperplasia prostatica. - Google Patents

Impiego di antiestrogeni e antiandrogeni ad azione antigonadotropa per la profilassi e la terapia della iperplasia prostatica.

Info

Publication number
IT7921854A0
IT7921854A0 IT7921854A IT2185479A IT7921854A0 IT 7921854 A0 IT7921854 A0 IT 7921854A0 IT 7921854 A IT7921854 A IT 7921854A IT 2185479 A IT2185479 A IT 2185479A IT 7921854 A0 IT7921854 A0 IT 7921854A0
Authority
IT
Italy
Prior art keywords
antigonadotropa
antiestrogens
antiandrogens
prophylaxis
therapy
Prior art date
Application number
IT7921854A
Other languages
English (en)
Other versions
IT1119733B (it
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IT7921854A0 publication Critical patent/IT7921854A0/it
Application granted granted Critical
Publication of IT1119733B publication Critical patent/IT1119733B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT21854/79A 1978-04-17 1979-04-13 Impiego di antiestrogeni e antiandrogeni ad azione antigonadotropa per la profilassi e la terapia della iperplasia prostatica IT1119733B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19782817157 DE2817157A1 (de) 1978-04-17 1978-04-17 Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie

Publications (2)

Publication Number Publication Date
IT7921854A0 true IT7921854A0 (it) 1979-04-13
IT1119733B IT1119733B (it) 1986-03-10

Family

ID=6037493

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21854/79A IT1119733B (it) 1978-04-17 1979-04-13 Impiego di antiestrogeni e antiandrogeni ad azione antigonadotropa per la profilassi e la terapia della iperplasia prostatica

Country Status (13)

Country Link
US (1) US4310523A (it)
JP (1) JPS5513261A (it)
AU (1) AU528179B2 (it)
BE (1) BE875634A (it)
CA (1) CA1134271A (it)
CH (1) CH641679A5 (it)
DE (1) DE2817157A1 (it)
GB (1) GB2018591B (it)
IT (1) IT1119733B (it)
LU (1) LU81153A1 (it)
NL (1) NL7901961A (it)
SE (1) SE441977B (it)
ZA (1) ZA791797B (it)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3121152A1 (de) * 1981-05-22 1982-12-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen "verwendung der kombination eines aromatase-hemmers mit einem antiandrogen zur prophylaxe und therapie der prostatahyperplasie"
DE3121153A1 (de) * 1981-05-22 1982-12-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen "verwendung von aromatase-hemmern zur prophylaxe und therapie der prostatahyperplasie"
DE3339295A1 (de) * 1982-11-15 1984-05-17 Schering AG, 1000 Berlin und 4709 Bergkamen 4-hydroxy- und 4-acyloxy-4-androsten-3,17-dione zur verwendung bei der prophylaxe und therapie der prostatahyperplasie und diese enthaltende mittel fuer derartige verwendung
WO1985002543A1 (en) * 1983-12-12 1985-06-20 Kaszynski Edwin G Hair growth modification
US4885289A (en) * 1983-12-12 1989-12-05 Breuer Miklos M Alteration of character of male beard growth
DE3607651A1 (de) * 1986-03-06 1987-09-10 Schering Ag Kombination von aromatasehemmer und testosteron-5(alpha)-reduktase-hemmer
US4895715A (en) * 1988-04-14 1990-01-23 Schering Corporation Method of treating gynecomastia
US5116615A (en) * 1989-01-27 1992-05-26 Immunolytics, Inc. Method for treating benign prostatic hypertrophy
WO1990008555A1 (en) 1989-01-27 1990-08-09 Immunolytics, Inc. Composition and method for treating benign prostatic hypertrophy
US5595985A (en) 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
DE69033020T2 (de) * 1989-07-07 1999-08-05 Endorecherche Inc Kombinationstherapie zur prophylaxe und/oder behandlung benigner prostatahyperplasie
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5411991A (en) * 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
US6743419B1 (en) 1992-12-22 2004-06-01 The Gillette Company Method of reducing hair growth employing sulfhydryl active compounds
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
CA2170400A1 (en) * 1994-06-27 1996-01-04 M. Frederick Hawthorne Boron-containing hormone analogs and methods of their use in imaging or killing cells having hormone receptors
US20030083733A1 (en) * 1997-10-10 2003-05-01 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5837313A (en) * 1995-04-19 1998-11-17 Schneider (Usa) Inc Drug release stent coating process
US6099562A (en) * 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
US20020091433A1 (en) * 1995-04-19 2002-07-11 Ni Ding Drug release coated stent
WO1996040150A1 (en) * 1995-06-07 1996-12-19 Merck & Co., Inc. Treatment and prevention of prostatic disease
US5726202A (en) * 1996-01-11 1998-03-10 Novo Nordisk A/S Benign prostatic hypertrophy
US6117911A (en) * 1997-04-11 2000-09-12 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies
EP1094798A2 (en) * 1998-03-11 2001-05-02 Endorecherche Inc. INHIBITORS OF TYPE 5 AND TYPE 3 17beta-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE
EP1321146A3 (en) * 1998-03-11 2004-06-02 Endorecherche Inc. Inhibitors of type 5 and 3 17beta-hydroxysteroid dehydrogenase and methods for their use
DE19825591A1 (de) * 1998-06-09 1999-12-23 Jenapharm Gmbh Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
EP1175433B1 (en) 1999-05-04 2005-08-03 Strakan International Limited Androgen glycosides and androgenic activity thereof
PT1955700E (pt) 1999-09-30 2011-05-04 Harbor Biosciences Inc Tratamento terap?utico de doen?as associadas ao receptor de androg?nios
AU2001288213B2 (en) * 2000-06-28 2005-04-14 Bristol-Myers Squibb Company Selective androgen receptor modulators and methods for their identification, design and use
EP1324754A1 (en) * 2000-07-05 2003-07-09 AstraZeneca AB Pharmaceutical combination of an anti-androgen and tamoxifen for providing an anti-androgenic effect and aromatase inhibition
US6613083B2 (en) * 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
US7332525B2 (en) * 2003-01-17 2008-02-19 Castle Erik P Method of treatment of prostate cancer and composition for treatment thereof
US20090291134A1 (en) 2006-11-21 2009-11-26 Jina Pharmaceuticals, Inc. Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases
PT2101731T (pt) 2006-11-21 2018-04-18 Jina Pharmaceuticals Inc Endoxifeno para utilização no tratamento de cancro
EA022208B1 (ru) * 2008-10-10 2015-11-30 Тева Вимен'С Хелс, Инк. Способы лечения вазомоторных симптомов у кастрированных пациентов с раком предстательной железы низкими дозами ципротерона ацетата
US20160361380A1 (en) 2015-06-12 2016-12-15 Nymox Corporation Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
US10183058B2 (en) 2016-06-17 2019-01-22 Nymox Corporation Method of preventing or reducing the progression of prostate cancer
US10172910B2 (en) 2016-07-28 2019-01-08 Nymox Corporation Method of preventing or reducing the incidence of acute urinary retention
US10532081B2 (en) 2016-09-07 2020-01-14 Nymox Corporation Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10335453B2 (en) 2017-03-01 2019-07-02 Nymox Corporation Compositions and methods for improving sexual function

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076823A (en) * 1961-07-03 1963-02-05 Syntex Corp Process for the production of 6-chloro-3-keto-deta steroid compounds
US3423507A (en) * 1966-02-25 1969-01-21 Schering Corp Method of treating benign prostratic hypertrophy
US4055641A (en) * 1976-05-10 1977-10-25 Richardson-Merrell Inc. Method of treating benign prostatic hypertrophy

Also Published As

Publication number Publication date
DE2817157A1 (de) 1979-10-25
NL7901961A (nl) 1979-10-19
GB2018591A (en) 1979-10-24
AU528179B2 (en) 1983-04-21
BE875634A (fr) 1979-10-17
CA1134271A (en) 1982-10-26
IT1119733B (it) 1986-03-10
LU81153A1 (de) 1979-06-19
JPS5513261A (en) 1980-01-30
SE7903240L (sv) 1979-10-18
SE441977B (sv) 1985-11-25
JPS645007B2 (it) 1989-01-27
CH641679A5 (de) 1984-03-15
US4310523A (en) 1982-01-12
AU4560479A (en) 1979-10-25
GB2018591B (en) 1982-09-08
ZA791797B (en) 1980-11-26

Similar Documents

Publication Publication Date Title
IT7921854A0 (it) Impiego di antiestrogeni e antiandrogeni ad azione antigonadotropa per la profilassi e la terapia della iperplasia prostatica.
IT8123988A0 (it) Impiego della combinazione di un inibitore della aromatasi con un antiandrogeno per la profilassi ela terapia dell'iperplasia della prostata.
IT7925406A0 (it) Ringhiera e procedimento di costruzione della stessa.
IT8124117A0 (it) Impiego di inibitori dell'aromatasi per la profilassi e la terapia della iperplasia della prostata.
IT7823694A0 (it) Punta di fornello con stelo o gambo amovibile.
IT8223892A0 (it) Composizione di antralina migliorata e suo uso nel trattamento di malattie della pelle.
NL7904543A (nl) Luier of dergelijke.
IT1140088B (it) Bioprotesi valvolare cardiaca e suo procedimento di ottenimento
IT1069522B (it) Procedimento per la preparazione di butandiolo e..o butendiolo
ES277890Y (es) Conjunto aislador del calor y del ruido.
IT7823639V0 (it) Dispositivo di riscontro e riparazione della scocca di autoveicoli sinistrati.
IT1062619B (it) Procedimento ed impianto per la depurazione di-stillativa di 2.5 diosso i ossa 2 fosfolani
IT8222328A0 (it) Procedimento per il consolidamento e/o la stabilizzazione del terreno.
IT7923065A0 (it) Procedimento e dispositivo per la determinazione della direzione di guasto.
IT8019370A0 (it) Struttura di sedia o poltrona.
IT8567632A0 (it) Procedimento per la fabbricazione di pezzi sagomati piatti e dispositivo per l attuazione del procedimento
GR80629B (en) Pharmacologically active diarylindane -1,3-diones
NO166084C (no) Fremgangsmaate for fremstilling av miljoevennlige fnokningsmiddelorganosoler og anvendelse derav.
IT8021641A0 (it) Alogeno-derivati della isopropilamminopirimidina, loro preparazione e impiego terapeutico.
IT1059875B (it) Benzodiossani 1..4 loro procedimento di preparazione e loro applicazione in terapia
IT1084630B (it) Valvola di ritenuta e impiego della stessa.
IT7827394A0 (it) Procedimento per la preparazione di maltosio-fosforilasi o/e di bet-fosfoglucosio-mutasi e loro impiego.
IT1141221B (it) Analoghi della 6.9-nitrilo-prostaglandina
IT7921058A0 (it) Procedimento e dispositivo per la fabbricazione di pasta di legno.
IT7804236V0 (it) Congiunzione di pannelli per mobili e simili.